Nanoformulations further amplify these effects: for instance, quercetin-loaded polymeric nanoparticles achieve sustained Akt inhibition in breast cancer cells, reducing phosphorylated Akt levels significantly more than free quercetin [119]. Here, AKT1 is linked to breast cancer.